EPHA2 and nasopharyngeal carcinoma: Moreover, the decrease of EphA2 protein in the MBZ-treated NPC cells was specifically reversed by treatment with MG132 (Fig. 3E), suggesting that MBZ induces EphA2 degradation via a ubiquitin proteasome pathway.